Kanker-actueel Lung cancer: recent developments and important studies and articles in mainstream oncology put together. An overview. Update July 20, 2010

recente ontwikkelingen bij longkanker

Startpagina

Contact | Disclaimer | Sitehulp

Sitemap | Video's

Patiëntenervaringen | Lotgenotencontact

Forum |

Onze Sponsors

Cancer Types

Regular

Complementary

Coaching

Donations

Questions

Cancer News

Addresses

Prevention

Recipes

Artikelen

Angionese inhibitor, Vadimesam (ASA404, chemo, gives no positive effect in lung cancer, says phase III trial results. Article posted July 12, 2011

General: If five years clinically free of lung cancer does not always have to. Too often results in a relapse again after five years and who is now 10 years screening proposed. Article posted July 20, 2010

Irradiation with 70 GY 1x per day in non-small-cell lung cancer is as effective as chemotherapy, said Phase II study with 63 patients. Article updated July 10, 2011

Irradiation: Deferral of radiotherapy - radiotherapy after chemotherapy leads to significantly shorter lifespan and premature mortality from non-small-cell lung cancer and more incurable lung cancer patients. Appears partly in doctoral research radiologist el Sharouni. Article updated July 10, 2011

Chemo: Uracil-tagafur (UFT) increases risk five years survival from 74% to 85% in NSCLC patients after surgical removal of lung tumors. Meta-analysis confirms the good results. Article updated July 12, 2011

Chemo: Platinum-based chemotherapy provide similar results on survival and overall survival time than non platinum-based chemotherapy. But the side effects of platinum-based chemotherapy are two to three times larger and more serious shows meta-analysis of randomized trials. Article updated August 11, 2011

Chemo plus radiation therapy in elderly people with lung cancer compared with radiation alone longer life (from 10.5 to 13.7 months median), but the high quality of life is significantly less than with radiation alone. Article updated July 10, 2011

Chemotherapy after surgery in non-small-cell lung cancer patients stage I, II and IIIA has no demonstrable positive effect on recurrence or successful treatment, says a large randomized phase III study. Please read below the abstract of this study published back in 2003. Article updated July 10, 2011

Chemo: chemotherapy with Navelbine combination - cisplatin and vinorelbine shows in operable lung cancer patients (stage I and II) positive effect on five-year survival compared with placebo, shows 10-year randomized study in 482 patients. Article updated July 10, 2011

Chemotherapy: Irinotecan plus Gemcitabine shows no difference compared to irinotecan alone in advanced non-small cell lung cancer survival and time to recurrence, something fewer side effects, but these were not significant Article updated July 10, 2011

Chemo: Thalidomide chemo gives shorter median survival for non-small-cell lung cancer and severe adverse events (thrombosis) compared with placebo. Thus, randomized placebo-controlled phase III study. Article updated July 10, 2011

Chinese herbs in addition to Baic = chemo embolization of bronchial cancer will improve survival significantly - doubling from two-year survival of 24% to 51% - and significantly fewer side said randomized study in 76 lung cancer patients. Article updated August 11, 2011

CT scan shows 33% percent false-positive results in lung cancer and appear unreliable as a measuring tool for lung cancer. Article updated July 10, 2011

Hormones: Women taking estrogen plus progestin have been given to control symptoms of menopause after 5 years had a significantly higher mortality from non-small cell lung cancer (NSCLC) than women who had used no hormones. Of the 96 patients who developed cancer died 69 for the fifth year was achieved and 39 of the 72 lung cancer patients died before the fifth year was achieved in the placebo group. Article updated July 10, 2011

Hydrazine sulfate would significantly diminish side effects chemo cocktail and median lifespan by 40 percent in non-small-cell lung cancer patients according to randomized study in 65 patients with non-small-cell lung cancer, but other randomized phase III study shows no difference in effect seen . Article updated July 10, 2011

Immunotherapy: 131I-antibody chTNT a drug injected directly into the tumors in inoperable lung cancer patients will once again achieved remarkable results in Phase I-II studies.N. Article updated August 11, 2011

Iressa - Gefitinib and Tarceva - Erlotinib: a review of major studies and recent publications.

Litt - Laser-induced Interstitial Thermal Therapy seems excellent approach for lung cancer using very fine equipment, and where the cancer tumor to tumor addressed. Not all at once. Article updated August 11, 2011

Surgery for lung cancer in the summer gives significantly better results, fewer relapses, than operate in the winter or spring. Vitamin D. appears to play a major role. The 5-year survival is less than 42% higher in summer operation and vitamin D. intake than surgery in the winter and lowest vitamin D. intake. A remarkable study results. Article updated July 10, 2011

RFA - radiofrequency ablation and radiation together with inoperable lung cancer doubles lifespan compared with radiation alone. Article updated August 11, 2011.

RSR 13 - efaproxiral - shows in addition to irradiation of non-small cell lung cancer, significant and encouraging results in two Phase II studies in patients 52 and 51. Article updated July 10, 2011

Stereotactic irradiation with the Gamma Knife provides significantly good results in survival time in addressing hersenuitzaaiïngen from lung cancer. Article updated July 10, 2011

Stereotactic radiation therapy and new surgical techniques in elderly patients (SARB) with stage I lung cancer give excellent results in survival time. Median survival time was 24.1 months from 16.8 months to, says Dutch study. Article posted July 15, 2011

Stereotactic radiation in inoperable lung cancer patients proves much more effective and safer with fewer side effects than traditional radiation therapy of lung tumors after surgery. Thus phase I / II trial in 47 and 70 Phase II trial in inoperable lung cancer patients. Article updated July 10, 2011

Diet and nutritional supplementation: High dose supplementation - vitamins C, E and beta carotene - chemo - paclitaxel and carboplatin - gives more complete remissions and longer survival than chemotherapy alone in patients with non-small-cell lung cancer. Article updated July 10, 2011

Silver nitrate is at least as good as talc lung and pleura problems (inflammation / fluid) against. Talk is already superior to doxorubicin chemotherapy and now it seems more effective than silver nitrate talc. Article updated August 11, 2011

Gemcitabine and cisplatin chemotherapy in non-small-cell lung cancer to bridge time to radiotherapy provides very poor results says Dutch study. After the chemotherapy doubled the growth of tumors compared to control group not receiving chemotherapy. Article updated July 10, 2011

Chemo combination of prednisone, azathioprine, and N-acetylcysteine (NAC) for lung fibrosis and fails phase III study is discontinued immediately due to large difference in mortality compared with placebo group. article posted October 23, 2011

Chemo: two types of chemo also gives in the elderly doubling of disease-free survival in non-significant time and overall better small-cellige lung cancer compared with only a form of chemo. Phase III study shows, and others about is to notice. Article

Fish oil and fish oil gives significantly improves response chance of chemo chemotherapy significantly longer median survival in non-next to small-cellige lung cancer. Article

-Alimta (Pemetrexed) approved by FDA and now also in Europe for non-small-cellige lung cancer as maintenance therapy after previously authorised for use in mesothelioma after excellent study results with significantly longer median survival and with far fewer side effects than traditional chemotherapy. Article

Epigenetic treatment with Azacitidine entinostat and provides spectacular good results in non-small-cellige uitbehandelde patients with lung cancer. Scientists call these epigenetic therapy an absolute breakthrough for treatment of solid tumors.

Lung cancer: recent developments and important studies and articles in mainstream oncology put together. An overview. Update July 20, 2010

In the left column we have a number of recent developments and key study results from the mainstream oncology put together in more or less alphabetical order, So we all articles about eg chemo put together with chemotherapy as the first word etc.. Among cancers - lung cancer is much more information. Also non-toxic products and complementary treatments and stories of lung cancer patients.